CD4 and myeloid sarcoma: MS is regarded as an autoimmune disease since inflammatory lesions associated with the disease are well-characterized by blood brain barrier (BBB) leakage and massive lymphocytic infiltration, principally the participation of the CD4+ T cells (Brück, 2005; Comabella and Khoury, 2012).